Biochemical and Biophysical Research Communications 1998-03-17

Biochemical evidence for oligomerization of rat adrenal acyl-coenzyme A:cholesterol acyltransferase.

T Kawasaki, A Miyazaki, H Hakamata, H Matsuda, S Horiuchi

Index: Biochem. Biophys. Res. Commun. 244(2) , 347-52, (1998)

Full Text: HTML

Abstract

Acyl-coenzyme A:cholesterol acyltransferase (ACAT) in rat adrenal was compared with that in rat liver. Immunoblot analyses of the microsomal fractions from adrenal with an anti-human ACAT antibody detected a 45 kDa protein. Upon pretreatment of these microsomal fractions with chemical cross-linkers such as BS3 and Sulfo-EGS, the 45 kDa band decreased with a concomitant increase in high molecular weight proteins (55, approximately 100, and approximately 230 kDa), suggesting that ACAT constitutes oligomers of 45 kDa monomers associated with a 10 kDa protein. In sharp contrast, the same immunoblot analysis of rat liver microsomal fractions identified a 50 kDa protein which was not cross-linked by these cross-linkers. Moreover, when four ACAT inhibitors were tested for their effects on adrenal and liver enzymes, NTE-122, CI-976, and E5324 were more effective for the liver enzyme, whereas 58-035 was much more effective for adrenal ACAT. These biochemical and pharmacological observations support the notion that the rat liver ACAT protein is distinct from the adrenal counterpart.


Related Compounds

Related Articles:

cPLA2α and EHD1 interact and regulate the vesiculation of cholesterol-rich, GPI-anchored, protein-containing endosomes.

2012-05-01

[Mol. Biol. Cell 23(10) , 1874-88, (2012)]

Use of acyltransferase inhibitors to block vesicular traffic between the ER and Golgi complex.

2005-01-01

[Meth. Enzymol. 404 , 115-25, (2005)]

A unique lysophospholipid acyltransferase (LPAT) antagonist, CI-976, affects secretory and endocytic membrane trafficking pathways.

2005-07-15

[J. Cell Sci. 118(Pt 14) , 3061-71, (2005)]

In vitro and in vivo disposition of 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide (CI-976). Identification of a novel five-carbon cleavage metabolite in rats.

1997-01-01

[Drug Metab. Dispos. 25(1) , 123-30, (1997)]

The lysophospholipid acyltransferase antagonist CI-976 inhibits a late step in COPII vesicle budding.

2008-05-01

[Traffic 9(5) , 786-97, (2008)]

More Articles...